Skip to main content

Lisa Kuhns, PhD, MD

News
02/13/2025
Durvalumab immunotherapy improves survival in unresectable stage III non-small cell lung cancer (NSCLC), but its high cost makes it prohibitive globally under current pricing models, according to study results published in JAMA Network Open.
Durvalumab immunotherapy improves survival in unresectable stage III non-small cell lung cancer (NSCLC), but its high cost makes it prohibitive globally under current pricing models, according to study results published in JAMA Network Open.
Durvalumab immunotherapy...
02/13/2025
Journal of Clinical Pathways
News
02/12/2025
Consolidative autologous hematopoietic cell transplant (auto-HCT) provides no additional benefit for patients with mantle cell lymphoma (MCL) achieving undetectable minimal residual disease (uMRD6) in their first complete remission (CR),...
Consolidative autologous hematopoietic cell transplant (auto-HCT) provides no additional benefit for patients with mantle cell lymphoma (MCL) achieving undetectable minimal residual disease (uMRD6) in their first complete remission (CR),...
Consolidative autologous...
02/12/2025
Journal of Clinical Pathways
News
02/10/2025
Individuals with multiple sclerosis (MS) experience an ongoing impact of post-COVID-19 symptoms, revealing a significant overlap between post-acute sequelae of SARS-CoV-2 infection (PASC) and MS-related symptoms.
Individuals with multiple sclerosis (MS) experience an ongoing impact of post-COVID-19 symptoms, revealing a significant overlap between post-acute sequelae of SARS-CoV-2 infection (PASC) and MS-related symptoms.
Individuals with multiple...
02/10/2025
First Report Managed Care
NPF Endorsed Features
02/03/2025
The National Psoriasis Foundation’s first-ever health indicator report takes a deep dive into the health burden of psoriatic disease, treatment gaps, and future directions in care.
The National Psoriasis Foundation’s first-ever health indicator report takes a deep dive into the health burden of psoriatic disease, treatment gaps, and future directions in care.
The National Psoriasis...
02/03/2025
The Dermatologist
News
01/21/2025
The RSV vaccine Abrysvo (RSVpreF) is highly effective in preventing severe respiratory syncytial virus (RSV) infections in adults aged 60 and older.
The RSV vaccine Abrysvo (RSVpreF) is highly effective in preventing severe respiratory syncytial virus (RSV) infections in adults aged 60 and older.
The RSV vaccine Abrysvo...
01/21/2025
Pharmacy Learning Network
News
01/20/2025
In the first year of biosimilar competition for adalimumab, spending on the drug decreased by nearly 50%, yet biosimilars accounted for less than 2% of prescriptions in the US.
In the first year of biosimilar competition for adalimumab, spending on the drug decreased by nearly 50%, yet biosimilars accounted for less than 2% of prescriptions in the US.
In the first year of biosimilar...
01/20/2025
First Report Managed Care
News
01/13/2025
Patients with vitiligo in the US face significantly higher health care costs and resource utilization compared with the general population, according to a study published in the Journal of Investigative Dermatology.
Patients with vitiligo in the US face significantly higher health care costs and resource utilization compared with the general population, according to a study published in the Journal of Investigative Dermatology.
Patients with vitiligo in the US...
01/13/2025
First Report Managed Care
News
01/10/2025
Biosimilar versions of trastuzumab have rapidly gained market share in treating HER2-positive breast cancer since their introduction to the US markets.
Biosimilar versions of trastuzumab have rapidly gained market share in treating HER2-positive breast cancer since their introduction to the US markets.
Biosimilar versions of...
01/10/2025
First Report Managed Care
News
01/10/2025
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened...
01/10/2025
Pharmacy Learning Network
News
12/27/2024
Despite federal rules aimed at empowering patients with clear medical pricing information, hospitals are still falling short in providing transparent data, according to a recent report by Patient Rights Advocate (PRA).
Despite federal rules aimed at empowering patients with clear medical pricing information, hospitals are still falling short in providing transparent data, according to a recent report by Patient Rights Advocate (PRA).
Despite federal rules aimed at...
12/27/2024
Integrated Healthcare Executive